Laser mammography developer Imaging Diagnostic Systems announcedthis month that its stock will be listed on theNASDAQ stock exchange.The Plantation, FL, company, which is developing a mammographyscanner that uses laser light rather than x-rays, said the
Laser mammography developer Imaging Diagnostic Systems announcedthis month that its stock will be listed on theNASDAQ stock exchange.The Plantation, FL, company, which is developing a mammographyscanner that uses laser light rather than x-rays, said the moveshould help analysts and investors follow its stock more closely.IDSI's stock had been trading on the OTC Bulletin Board.
In other IDSI news, the company announced that it will conductphase I clinical trials for its CT Laser Mammography device atColumbia JFK Medical Center in Atlantis, FL. IDSI will submitan amendment to its existing investigational device exemption(IDE) to incorporate Columbia JFK as a clinical site. Once theamendment is accepted, IDSI will be able to use the hospital'sextensive database of patients with breast abnormalities.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.